[Hot Stock] SillaJen Rises on Start of Animal Trials for COVID-19 Vaccine Candidate
[Asia Economy Reporter Geum Bo-ryeong] SillaJen showed strong performance on the 27th following news that it will begin animal testing of its novel coronavirus (COVID-19) vaccine candidates.
At 2:30 PM that day, SillaJen's stock price rose 6.07% (750 KRW) compared to the previous close, reaching 13,100 KRW.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- NVIDIA Reports $81.6 Billion in Q1 Revenue, Surpassing Expectations
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
On the 24th (local time), SillaJen announced that it had started animal testing in Canada to verify whether two COVID-19 vaccine candidates induce antibody production. The expected duration of the animal testing is six weeks.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
